NDANASALSPRAYPriority Review
Approved
May 2023
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1
Data completeness
3/8 — Basic
Priority Review
Drug data last refreshed 13h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OPVEE (nalmefene hydrochloride) is a nasal spray formulation of nalmefene, an opioid antagonist indicated for emergency treatment of opioid overdose. Nalmefene rapidly reverses opioid-induced respiratory depression by competitively blocking opioid receptors. The product represents a needle-free alternative to existing opioid reversal agents.
Peak15.9 years to LOE
Recently approved product in peak lifecycle stage suggests commercial team is building out distribution and market penetration, though current job openings are limited.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence
Started Oct 2019
533 enrolled
Alcohol Dependence
Career Relevance
OPVEE offers career opportunities in a newly approved emergency care product with long patent exclusivity and low current competitive pressure. Positions are likely concentrated in commercial launch execution, medical education, and market access for this specialized naloxone alternative.
Brand Manager
Worked on OPVEE at Indivior? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.